Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Ingredients Active Agents: BPC-157 (Pentadecapeptide) 10mg, TB-500 (Thymosin Beta-4 Analog) 10mg, KPV (Tripeptide) 10mg, GHK-Cu (Copper Tripeptide-1) 50mg Format: Sterile Lyophilized Powder (requires reconstitution) Total Concentration: 80mg per vial (Proprietary Research Ratio) Purity: 99% (HPLC Verified for all components)
The extent of the enzymatic reaction was calculated using the equation I% = [(CT)/C] 100, where I% is the activity of the enzyme given as percentage inhibition, C is the absorbance of the control solvent (blank) in the presence of the enzyme, and T is the absorbance of the test sample or positive control/reference inhibitor (i.e., galantamine) in the solvent in the presence of the enzyme
1 2 3 "Carnitine Shuttle and Ferroptosis in Cancer"
Retrieved May 10, 2025 via Naver
(Does not apply to prepayment).
Biological actions of GLP-1, source: reference [1] Evolution of GLP1 GLP-1RAs Currently, there are nine GLP-1RAs approved for marketing worldwide (Table 1), mainly for the treatment of diabetes and obesity, of which tirzepatide is a novel dual GLP-1RA/GIPR agonist
US$ 24.10
US$ 28.31
US$ 20.86
US$ 23.65
